54 related articles for article (PubMed ID: 17982487)
1. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions.
Yu J; Liu P; Cui X; Sui Y; Ji G; Guan R; Sun D; Ji W; Liu F; Liu A; Zhao Y; Yu Y; Jin Y; Bai J; Geng J; Xue Y; Qi J; Lee KY; Fu S
Mol Cells; 2011 Jul; 32(1):47-55. PubMed ID: 21533545
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
Ferraresso S; Bresolin S; Aricò A; Comazzi S; Gelain ME; Riondato F; Bargelloni L; Marconato L; Kronnie Gt; Aresu L
PLoS One; 2014; 9(4):e92707. PubMed ID: 24695110
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.
Monti S; Chapuy B; Takeyama K; Rodig SJ; Hao Y; Yeda KT; Inguilizian H; Mermel C; Currie T; Dogan A; Kutok JL; Beroukhim R; Neuberg D; Habermann TM; Getz G; Kung AL; Golub TR; Shipp MA
Cancer Cell; 2012 Sep; 22(3):359-72. PubMed ID: 22975378
[TBL] [Abstract][Full Text] [Related]
5. Distinct oncogenic phenotypes in hematopoietic specific deletions of Trp53.
Palanichamy JK; Tran TM; King JK; Katzman S; Ritter AJ; Sharma G; Tso C; Contreras JR; Fernando TR; Sanford JR; Rao DS
Sci Rep; 2023 May; 13(1):7490. PubMed ID: 37160922
[TBL] [Abstract][Full Text] [Related]
6. A tale of two alleles: TP53 and transformation in MPNs.
Brierley C; Psaila B
Blood; 2022 Jun; 139(25):3567-3568. PubMed ID: 35737408
[No Abstract] [Full Text] [Related]
7. Progressive
Tzioni MM; Clipson A; Chen Z; Cucco F; Wotherspoon A; Dojcinov S; Du MQ
Leuk Lymphoma; 2024 Mar; ():1-5. PubMed ID: 38516899
[No Abstract] [Full Text] [Related]
8. Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas.
Horn H; Jurinovic V; Leich E; Kalmbach S; Bausinger J; Staiger AM; Kurz KS; Möller P; Bernd HW; Feller AC; Koch K; Klapper W; Stein H; Hansmann ML; Hartmann S; Scheubeck G; Dreyling M; Hiddemann W; Herfarth K; Engelhard M; Rosenwald A; Hoster E; Ott G
Hemasphere; 2022 Sep; 6(9):e767. PubMed ID: 35974958
[TBL] [Abstract][Full Text] [Related]
9. From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity.
Kanduc D; Shoenfeld Y
Glob Med Genet; 2020 Aug; 7(2):51-63. PubMed ID: 32939516
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer.
Sun X; Qu Q; Lao Y; Zhang M; Yin X; Zhu H; Wang Y; Yang J; Yi J; Hao M
BMC Cancer; 2019 Dec; 19(1):1180. PubMed ID: 31795965
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.
Voropaeva EN; Pospelova TI; Voevoda MI; Maksimov VN; Orlov YL; Seregina OB
BMC Med Genomics; 2019 Mar; 12(Suppl 2):35. PubMed ID: 30871527
[TBL] [Abstract][Full Text] [Related]
12.
Dobashi A; Togashi Y; Tanaka N; Yokoyama M; Tsuyama N; Baba S; Mori S; Hatake K; Yamaguchi T; Noda T; Takeuchi K
Oncotarget; 2018 Apr; 9(28):19555-19568. PubMed ID: 29731965
[TBL] [Abstract][Full Text] [Related]
13. Numerical and structural genomic aberrations are reliably detectable in tissue microarrays of formalin-fixed paraffin-embedded tumor samples by fluorescence in-situ hybridization.
Horn H; Bausinger J; Staiger AM; Sohn M; Schmelter C; Gruber K; Kalla C; Ott MM; Rosenwald A; Ott G
PLoS One; 2014; 9(4):e95047. PubMed ID: 24733537
[TBL] [Abstract][Full Text] [Related]
14. The p53 Mutation/Deletion Profile in a Small Cohort of the Omani Population with Diffuse Large B-Cell Lymphoma.
Tamimi Y; Al-Harthy S; Al-Haddabi I; Al-Kindi M; Babiker H; Al-Moundhri M; Burney I
Sultan Qaboos Univ Med J; 2014 Feb; 14(1):e50-8. PubMed ID: 24516754
[TBL] [Abstract][Full Text] [Related]
15. Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.
Zheng J; Xiong D; Sun X; Wang J; Hao M; Ding T; Xiao G; Wang X; Mao Y; Fu Y; Shen K; Wang J
Cancer Microenviron; 2012 Dec; 5(3):285-93. PubMed ID: 22528874
[TBL] [Abstract][Full Text] [Related]
16. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro.
Cheung BB; Koach J; Tan O; Kim P; Bell JL; D'andreti C; Sutton S; Malyukova A; Sekyere E; Norris M; Haber M; Kavallaris M; Cunningham AM; Proby C; Leigh I; Wilmott JS; Cooper CL; Halliday GM; Scolyer RA; Marshall GM
J Pathol; 2012 Feb; 226(3):451-62. PubMed ID: 22009481
[TBL] [Abstract][Full Text] [Related]
17. Role of E-cadherin gene in gall bladder cancer and its precursor lesions.
Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agrawal S
Virchows Arch; 2010 May; 456(5):507-14. PubMed ID: 20376482
[TBL] [Abstract][Full Text] [Related]
18. Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma.
Stöcklein H; Hutter G; Kalla J; Hartmann E; Zimmermann Y; Katzenberger T; Adam P; Leich E; Höller S; Müller-Hermelink HK; Rosenwald A; Ott G; Dreyling M
J Hematop; 2008 Sep; 1(2):85-95. PubMed ID: 19669207
[TBL] [Abstract][Full Text] [Related]
19. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
